These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. The prophylactic use of combined hydrogenated ergot alkaloids, dihydroergocornine, dihydroergocristine and dihydroergokryptine in migraine. BERCEL NA Am Pract Dig Treat; 1955 Mar; 6(3):348-52. PubMed ID: 14350151 [No Abstract] [Full Text] [Related]
14. The face of chronic migraine: epidemiology, demographics, and treatment strategies. Vargas BB; Dodick DW Neurol Clin; 2009 May; 27(2):467-79. PubMed ID: 19289226 [TBL] [Abstract][Full Text] [Related]
15. Rectal use of ergotamine tartrate and caffeine alkaloid for the relief of migraine. GRAHAM JR N Engl J Med; 1954 Jun; 250(22):936-8. PubMed ID: 13165929 [No Abstract] [Full Text] [Related]
16. [Clinical observations & successful treatment in the use of ergotamine compounds in 100 cases of migraine]. VON LUTTEROTTI Munch Med Wochenschr; 1959 May; 101(18):815-8. PubMed ID: 13666747 [No Abstract] [Full Text] [Related]
18. Migraine in the triptan era: lessons from epidemiology, pathophysiology, and clinical science. Bigal ME; Ferrari M; Silberstein SD; Lipton RB; Goadsby PJ Headache; 2009 Feb; 49 Suppl 1():S21-33. PubMed ID: 19161562 [TBL] [Abstract][Full Text] [Related]
19. Triptans and ergot alkaloids in the acute treatment of migraine: similarities and differences. Tfelt-Hansen PC Expert Rev Neurother; 2013 Sep; 13(9):961-3. PubMed ID: 23980649 [No Abstract] [Full Text] [Related]